191 related articles for article (PubMed ID: 12632073)
1. High expression of the novel endothelin-converting enzyme genes, Nbla03145/ECEL1alpha and beta, is associated with favorable prognosis in human neuroblastomas.
Kawamoto T; Ohira M; Hamano S; Hori T; Nakagawara A
Int J Oncol; 2003 Apr; 22(4):815-22. PubMed ID: 12632073
[TBL] [Abstract][Full Text] [Related]
2. Low expression of human tubulin tyrosine ligase and suppressed tubulin tyrosination/detyrosination cycle are associated with impaired neuronal differentiation in neuroblastomas with poor prognosis.
Kato C; Miyazaki K; Nakagawa A; Ohira M; Nakamura Y; Ozaki T; Imai T; Nakagawara A
Int J Cancer; 2004 Nov; 112(3):365-75. PubMed ID: 15382060
[TBL] [Abstract][Full Text] [Related]
3. Identification of novel human neuronal leucine-rich repeat (hNLRR) family genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas.
Hamano S; Ohira M; Isogai E; Nakada K; Nakagawara A
Int J Oncol; 2004 Jun; 24(6):1457-66. PubMed ID: 15138588
[TBL] [Abstract][Full Text] [Related]
4. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
5. The studies on the correlation for gene expression of tyrosine-kinase receptors and vascular endothelial growth factor in human neuroblastomas.
Zhang J; Zheng Y; Wang Y; Tong H
J Pediatr Hematol Oncol; 2010 Apr; 32(3):180-4. PubMed ID: 20186105
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of the candidate tumor suppressor gene ING1 is associated with poor prognosis in advanced neuroblastomas.
Takahashi M; Ozaki T; Todo S; Nakagawara A
Oncol Rep; 2004 Oct; 12(4):811-6. PubMed ID: 15375504
[TBL] [Abstract][Full Text] [Related]
7. Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsets.
Ohira M; Morohashi A; Inuzuka H; Shishikura T; Kawamoto T; Kageyama H; Nakamura Y; Isogai E; Takayasu H; Sakiyama S; Suzuki Y; Sugano S; Goto T; Sato S; Nakagawara A
Oncogene; 2003 Aug; 22(35):5525-36. PubMed ID: 12934113
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of MYCN, DDX1, TrkA, and TrkC gene transcripts expression in neuroblastoma.
de Souza DR; Sanabani SS; de Souza AC; Filho Odone V; Epelman S; Bendit I
Pediatr Blood Cancer; 2011 May; 56(5):749-56. PubMed ID: 21154590
[TBL] [Abstract][Full Text] [Related]
9. Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification.
Raschellà G; Cesi V; Amendola R; Negroni A; Tanno B; Altavista P; Tonini GP; De Bernardi B; Calabretta B
Cancer Res; 1999 Jul; 59(14):3365-8. PubMed ID: 10416595
[TBL] [Abstract][Full Text] [Related]
10. Expression of SMARCF1, a truncated form of SWI1, in neuroblastoma.
Takeuchi T; Nicole S; Misaki A; Furihata M; Iwata J; Sonobe H; Ohtsuki Y
Am J Pathol; 2001 Feb; 158(2):663-72. PubMed ID: 11159203
[TBL] [Abstract][Full Text] [Related]
11. Novel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library.
Behrends U; Jandl T; Golbeck A; Lechner B; Müller-Weihrich S; Schmid I; Till H; Berthold F; Voltz R; Mautner JM
Int J Cancer; 2002 Aug; 100(6):669-77. PubMed ID: 12209604
[TBL] [Abstract][Full Text] [Related]
12. Association between favorable neuroblastoma and high expression of the novel metalloproteinase gene, nbla3145/XCE, cloned by differential screening of the full-length-enriched oligo-capping neuroblastoma cDNA libraries.
Kawamoto T; Shishikura T; Ohira M; Takayasu H; Morohashi A; Takada N; Takahashi M; Suzuki Y; Sugano S; Hori T; Nakagawara A
Med Pediatr Oncol; 2000 Dec; 35(6):628-31. PubMed ID: 11107133
[TBL] [Abstract][Full Text] [Related]
13. The high level of hCDC10 gene expression in neuroblastoma may be associated with favorable characteristics of the tumor.
Nagata T; Takahashi Y; Asai S; Ishii Y; Mugishima H; Suzuki T; Chin M; Harada K; Koshinaga S; Ishikawa K
J Surg Res; 2000 Aug; 92(2):267-75. PubMed ID: 10896833
[TBL] [Abstract][Full Text] [Related]
14. Shc family expression in neuroblastoma: high expression of shcC is associated with a poor prognosis in advanced neuroblastoma.
Terui E; Matsunaga T; Yoshida H; Kouchi K; Kuroda H; Hishiki T; Saito T; Yamada S; Shirasawa H; Ohnuma N
Clin Cancer Res; 2005 May; 11(9):3280-7. PubMed ID: 15867224
[TBL] [Abstract][Full Text] [Related]
15. Genomic organisation of the mouse gene encoding endothelin-converting enzyme-1 (ECE-1) and mRNA expression of ECE-1 isoforms in murine tissues.
Lindenau S; von Langsdorff C; Saxena A; Paul M; Orzechowski HD
Gene; 2006 May; 373():109-15. PubMed ID: 16540265
[TBL] [Abstract][Full Text] [Related]
16. Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants.
Aoyama M; Asai K; Shishikura T; Kawamoto T; Miyachi T; Yokoi T; Togari H; Wada Y; Kato T; Nakagawara A
Cancer Lett; 2001 Mar; 164(1):51-60. PubMed ID: 11166915
[TBL] [Abstract][Full Text] [Related]
17. Expression of a MYCN-interacting isoform of the tumor suppressor BIN1 is reduced in neuroblastomas with unfavorable biological features.
Tajiri T; Liu X; Thompson PM; Tanaka S; Suita S; Zhao H; Maris JM; Prendergast GC; Hogarty MD
Clin Cancer Res; 2003 Aug; 9(9):3345-55. PubMed ID: 12960121
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas.
Machida T; Fujita T; Ooo ML; Ohira M; Isogai E; Mihara M; Hirato J; Tomotsune D; Hirata T; Fujimori M; Adachi W; Nakagawara A
Oncogene; 2006 Mar; 25(13):1931-42. PubMed ID: 16288218
[TBL] [Abstract][Full Text] [Related]
19. High expressions of neuronatin isoforms in favorable neuroblastoma.
Higashi M; Tajiri T; Kinoshita Y; Tatsuta K; Souzaki R; Maehara Y; Suita S; Taguchi T
J Pediatr Hematol Oncol; 2007 Aug; 29(8):551-6. PubMed ID: 17762496
[TBL] [Abstract][Full Text] [Related]
20. Reevaluation of trkA expression as a biological marker of neuroblastoma by high-sensitivity expression analysis--a study of 106 primary neuroblastomas treated in a single institute.
Hishiki T; Saito T; Terui K; Sato Y; Takenouchi A; Yahata E; Ono S; Nakagawara A; Kamijo T; Nakamura Y; Matsunaga T; Yoshida H
J Pediatr Surg; 2010 Dec; 45(12):2293-8. PubMed ID: 21129533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
